heavy period on semaglutide results week by week: timeline from first dose to full results GLP-1 medications: The next big

And remember: you dont have to suffer in silence

Obesity increases the risk of psychiatric disorders, and mental health conditions affect weight management challenges

But some experts are uneasy about the trend and flag several concerns and uncertainties

Individuals with significant body weight to lose, typically those with a BMI that qualifies for GLP-1 therapy and who have 30% or more body weight to lose, may benefit from the more aggressive metabolic intervention this combination provides

Common gastrointestinal side effects (nausea, vomiting, reduced appetite) may indirectly contribute to irritability or discomfort